Phill O’Neill
Phill has over 25 years’ experience in the use of pharmaceutical industry data and information. His research interests include the economics of the pharmaceutical market, the productivity, and outputs of NICE, and benchmarking industry performance. Phill was the lead analyst for several industry and Government economic benchmarking initiatives including the Pharmaceutical Industry Competitiveness Taskforce (PICTF) Indicators, Scottish Market Understanding Initiative, and G10 Competitiveness Indicators for the EU. Phill is a previous chair of the EFPIA Statistics Group.
Publications and Insights
- Publication: An Analysis of NICE’s Optimised Decisions from 2015 to 2024
- Publication: Analysing Global Immunisation Expenditure
- Insight: NICE at 25: Technology Appraisals – Faster Access to Modern Treatment?
- Publication: NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
- Insight: Can a continued focus on prevention, diagnosis, and treatment see the NHS to another 75 years?
- Publication: Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
- Publication: Realising the Broader Value of Vaccines in the UK
- Publication: NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?
- Publication: Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS
- Publication: The Impact of New Medicines in the NHS: 70 Years of Innovation
- Publication: R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
- Publication: Barriers to Uptake of Minimal Access Surgery in the United Kingdom
- Publication: Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries
- Publication: An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’
- Publication: Improving Efficiency and Resource Allocation in Future Cancer Care
- Publication: Assessing Trends in SMC Advice Decisions (October 2009- September 2015)
- Publication: International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective
- Publication: The Trajectory of Dementia in the UK – Making a Difference
- Publication: Projecting Expenditure on Medicines in the NHS: Second Edition
- Publication: The Influence of Cost-effectiveness and Other Factors on NICE Decisions
- Publication: Projecting Expenditure on Medicines in the NHS
- Publication: International Comparisons of Medicines Prices: 2011 Indices
- Publication: Time Trends in NICE HTA Decisions
- Publication: Health and the Use of Medicines in Primary Care in Wales
- Publication: Shedding the Pounds: Obesity Management, NICE Guidance and Bariatric Surgery in England
- Publication: Assessment of the Impact of Orphan Medicinal Products on the European Economy and Society